Know Cancer

or
forgot password

Dexamethasone as Palliative Treatment in Addition to Radiation Therapy for Patients With Brain Metastases: A Prospective Study


Phase 2
18 Years
N/A
Open (Enrolling)
Both
Neoplasm Metastasis

Thank you

Trial Information

Dexamethasone as Palliative Treatment in Addition to Radiation Therapy for Patients With Brain Metastases: A Prospective Study


Inclusion Criteria:



- Known diagnosis of cancer (even if primary unknown)

- Brain metastases (single or multiple) confirmed by imaging (CT, MRI)

- No contraindication for RT/steroids

- Patient will be treated with Whole Brain Radiation Therapy

- Informed consent

Exclusion Criteria:

- Primary cancer is lymphoma or leukemia

- Complete surgical excision of brain metastases

- Patient was on steroids for more then 2 weeks prior to entering the study

- Confusion or other factors that would impair ability to assess symptoms

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

To perform an adequate statistical evaluation of patients regarding the role of steroid therapy in managing patients with cerebral metastases.

Principal Investigator

Andrea Bezjak, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Princess Margaret Hospital, Canada

Authority:

Canada: Ethics Review Committee

Study ID:

UHN REB 03-0662-C

NCT ID:

NCT00188864

Start Date:

November 2003

Completion Date:

Related Keywords:

  • Neoplasm Metastasis
  • Neoplasms
  • Neoplasm Metastasis
  • Neoplasms, Second Primary

Name

Location